2-Chloro-6-methoxypyridin-4-amine, 95.0%, 250mg

4-Chloro-2-methoxypyridine, 95.0%, 1g

3,3-dimethyl-1-(3-pyridinyl)-1-butanamine, 95.0%, 5g

Chromatography columns with beaded rim with frit, 15 ml, 10 mm, 200 mm, 1 Piece(s)

2-Chloromethyl-3,5,6,7-tetrahydro-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one, 95.0%, 1g

Doxorubicin hydrochloride, 95.0%, 250mg

Methyl (1-(4-chlorophenyl)pent-4-en-2-yl)carbamate, 97%, 250mg

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethoxy)benzaldehyde, 97%, 1g

Diisopropyl ether, min. 98%, for synthesis, stab., 2.5 l, glass packaging

(S)-(+)-2,2-Dimethylcyclopropanecarboxamide>98.0%(GC)25g

2-Fluoro-5-methoxyphenylboronic acid, 98.0%, 1g

6-chloro-2-(2-thienyl)quinoline-4-carboxylic acid, 95.0%, 5g

6-Hydroxy-1-indanone, 95.0%, 1g